Suresh Poda

Suresh Poda is a Scientific Advisor at 1910 Genetics. Suresh has also worked as the Head of Biology at Eisai Center for Genetics Guided Dementia Discovery (G2D2), Senior Director at Denali Therapeutics, and Associate Director at Lundbeck. Poda has also worked as a Scientist at AstraZeneca.

Poda’s work experience has focused on pharmacology, assay development, bio-marker discovery, biotherapeutics PK/PD and antibody discovery. Suresh has been a project leader for BBB permeable ATV:Syn antibody project and a project agonist for human genetics validated Glial targets.

Poda’s education includes a PhD in Neuroscience from the University of California, Davis and a Bachelor of Science in Biological Sciences from the University of Mumbai.

Suresh Poda completed a management course at the MIT Sloan School of Management. Suresh then became a postdoctoral fellow at the University of Michigan. Lastly, they studied receptor pharmacology at Université de Montréal.